Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 24% ± 8% | |
lung | 7 studies | 23% ± 6% | |
brain | 7 studies | 32% ± 13% | |
bone marrow | 4 studies | 20% ± 3% | |
liver | 4 studies | 40% ± 28% | |
pancreas | 3 studies | 45% ± 6% | |
kidney | 3 studies | 19% ± 0% | |
eye | 3 studies | 23% ± 5% | |
lymph node | 3 studies | 17% ± 2% | |
intestine | 3 studies | 24% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4808.01 | 1445 / 1445 | 100% | 29.22 | 183 / 183 |
intestine | 100% | 5561.38 | 966 / 966 | 100% | 34.13 | 527 / 527 |
kidney | 100% | 7024.39 | 89 / 89 | 100% | 44.22 | 901 / 901 |
ovary | 100% | 5827.43 | 180 / 180 | 100% | 35.54 | 430 / 430 |
stomach | 100% | 4282.35 | 359 / 359 | 100% | 33.35 | 286 / 286 |
skin | 100% | 5511.42 | 1808 / 1809 | 100% | 119.44 | 472 / 472 |
brain | 100% | 4683.33 | 2640 / 2642 | 100% | 42.75 | 705 / 705 |
thymus | 100% | 11784.81 | 653 / 653 | 100% | 84.36 | 604 / 605 |
lung | 100% | 6787.24 | 578 / 578 | 100% | 37.68 | 1153 / 1155 |
prostate | 100% | 5090.61 | 245 / 245 | 100% | 34.84 | 501 / 502 |
uterus | 100% | 5566.97 | 170 / 170 | 100% | 38.03 | 458 / 459 |
breast | 100% | 5926.21 | 459 / 459 | 100% | 41.84 | 1115 / 1118 |
bladder | 100% | 5102.10 | 21 / 21 | 100% | 35.64 | 502 / 504 |
liver | 100% | 3893.49 | 226 / 226 | 100% | 37.88 | 404 / 406 |
pancreas | 97% | 2561.19 | 318 / 328 | 100% | 37.34 | 178 / 178 |
adrenal gland | 100% | 6599.74 | 258 / 258 | 97% | 40.27 | 222 / 230 |
adipose | 100% | 5788.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 91.87 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 44.09 | 29 / 29 |
peripheral blood | 100% | 22305.83 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 6951.00 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.16 | 1 / 1 |
blood vessel | 100% | 5481.69 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 2740.71 | 836 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 2029.86 | 777 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903599 | Biological process | positive regulation of autophagy of mitochondrion |
GO_0016567 | Biological process | protein ubiquitination |
GO_1903377 | Biological process | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
GO_0045620 | Biological process | negative regulation of lymphocyte differentiation |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0030098 | Biological process | lymphocyte differentiation |
GO_0040012 | Biological process | regulation of locomotion |
GO_1901526 | Biological process | positive regulation of mitophagy |
GO_0010975 | Biological process | regulation of neuron projection development |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0000422 | Biological process | autophagy of mitochondrion |
GO_0006626 | Biological process | protein targeting to mitochondrion |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0031647 | Biological process | regulation of protein stability |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0097414 | Cellular component | classical Lewy body |
GO_0005739 | Cellular component | mitochondrion |
GO_1990038 | Cellular component | Lewy body corona |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0097409 | Cellular component | glial cytoplasmic inclusion |
GO_1990037 | Cellular component | Lewy body core |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0097462 | Cellular component | Lewy neurite |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0043130 | Molecular function | ubiquitin binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FBXO7 |
Protein name | F-box protein 7 F-box only protein 7 |
Synonyms | FBX7 |
Description | FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins and plays a role in several biological processes such as cell cycle, cell proliferation, or maintenance of chromosome stability . Recognizes and ubiquitinates BIRC2 and the cell cycle regulator DLGAP5 . Plays a role downstream of PINK1 in the clearance of damaged mitochondria via selective autophagy (mitophagy) by targeting PRKN to dysfunctional depolarized mitochondria. Promotes MFN1 ubiquitination. Mediates the ubiquitination and proteasomal degradation of UXT isoform 2, thereby impairing the NF-kappa-B signaling pathway . Inhibits NF-kappa-B pathway also by promoting the ubiquitination of TRAF2 . Affects the assembly state and activity of the proteasome in the cells including neurons by ubiquitinating the proteasomal subunit PSMA2 via 'Lys-63'-linked polyubiquitin chains (By similarity). Promotes 'Lys-48'-linked polyubiquitination SIRT7, leading to the hydrogen peroxide-induced cell death . . |
Accessions | ENST00000452138.3 [Q9Y3I1-2] ENST00000425028.5 ENST00000397426.5 [Q9Y3I1-3] Q9Y3I1 ENST00000420700.5 F8WDR9 F8WBR0 ENST00000266087.12 [Q9Y3I1-1] ENST00000444207.1 A2A282 |